Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial. (2018)

First Author: Anderson RA
Attributed to:  MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(18)30500-x

PubMed Identifier: 30220622

Publication URI: http://europepmc.org/abstract/MED/30220622

Type: Journal Article/Review

Volume: 19

Parent Publication: The Lancet. Oncology

Issue: 10

ISSN: 1470-2045